Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 06-2019 | 04-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||
| Net Income | -4,862 | -4,862 | -4,862 |
| Depreciation Amortization | -37 | -37 | -37 |
| Other Working Capital | 1,230 | 1,230 | 1,230 |
| Other Operating Activity | 2,624 | 2,624 | 2,624 |
| Operating Cash Flow | $-1,045 | $-1,045 | $-1,045 |
| Cash Flows From Investing Activities | |||
| Other Investing Activity | 234 | 234 | 234 |
| Investing Cash Flow | $234 | $234 | $234 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 309 | 309 | 309 |
| Financing Cash Flow | $309 | $309 | $309 |
| Beginning Cash Position | 545 | 545 | 545 |
| End Cash Position | 43 | 43 | 43 |
| Net Cash Flow | $-502 | $-502 | $-502 |
| Free Cash Flow | |||
| Operating Cash Flow | -1,045 | -1,045 | -1,045 |
| Free Cash Flow | -1,045 | -1,045 | -1,045 |